Association between cardiometabolic comorbidity and mortality in patients with atrial fibrillation.

ABSTRACT:

Background

Patients with atrial fibrillation (AF) often suffer from cardiometabolic comorbidities, but the impact of the type and number of cardiometabolic comorbidities on the prognosis of AF patients remain unclear.

Methods

From August 2011 to December 2018, 23,838 AF patients from the Chinese Atrial Fibrillation Registry (China-AF) Study were enrolled in this study. The all-cause and cardiovascular-cause mortality was described. The Cox proportional hazard model was employed to explore the associations of the type and number of cardiometabolic comorbidities with all-cause and cardiovascular-cause mortality.

Results

During an average follow-up of 4.07 ± 1.96 years, 2,140 (8.98%) deaths were identified. The mortality in AF patients with cardiometabolic conditions was

SUBMITTER: Dong Z 

PROVIDER: S-EPMC12044800 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature